Methotrexate-Actinomycin-Chlorambucil Regimen

Known as: MAC, MAC Regimen 
A regimen consisting of methotrexate, dactinomycin (Actinomycin-D) and chlorambucil, used for the treatment of good-prognosis metastatic gestational… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE To compare the efficacy and safety of 3 different regimens, namely MAC, FLAG and CAG, as the re-induction chemotherapy… (More)
Is this relevant?
2016
2016
Reduced-intensity conditioning (RIC) has been shown to have similar overall survival (OS) but higher relapse rates compared with… (More)
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
2016
2016
Salvage regimens containing mitoxantrone have been successfully used for the treatment of primary induction failure or relapsed… (More)
  • figure 1
  • table I
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
Myeloablative conditioning (MAC) regimens are commonly used in transplantation for chronic granulomatous disease (CGD) but are… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 4
Is this relevant?
2015
2015
Refractory cytopenia of childhood (RCC) is the most common subtype of myelodysplastic syndrome in children, and the clinical… (More)
Is this relevant?
Review
2014
Review
2014
There is still some controversy regarding the optimal infused CD34 dose in allogeneic PBSC transplantation (PBSCT). Several… (More)
  • table 1
  • figure 1
Is this relevant?
2007
2007
BACKGROUND & OBJECTIVE Hematopoietic stem cell transplantation could improve the prognosis of malignant hematologic diseases… (More)
Is this relevant?
2006
2006
We assessed the safety and efficacy of melphalan, arsenic trioxide (ATO) and ascorbic acid (AA) (MAC) combination therapy for… (More)
Is this relevant?
1998
1998
A retrospective and comparative study of high-risk gestational trophoblastic tumor (GTT) treated with different chemoregimen from… (More)
Is this relevant?
1977
1977
A randomized trial of Adriamycin (A) in combination with melphalan (M), (MA therapy), and in combination with M plus… (More)
Is this relevant?